Evidence map›Paper›PMID 21460292›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2011

Interpreting assays for the detection of Streptococcus pneumoniae.

Anne J Blaschke

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Rapid detection ofFrontiers in cellular and infection microbiology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Streptococcus pneumoniae colonization in health care professionals at a tertiary university pediatric hospital.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Anne J BlaschkeDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah 84158, USA. anne.blaschke@hsc.utah.edu
University of Utah · US

Funding

HT-Film-Array: a system to assess respiratory viruses with emphasis on influenzaU01AI074419 · NIAID · BIOFIRE DEFENSE, LLC. · PI PORITZ, MARK AARON · 2007 to 2011
$8.2M
FilmArray Biothreat Pathogens: An Automated Multiplex PCR Diagnostic SystemU01AI082184 · NIAID · BIOFIRE DEFENSE, LLC. · PI OTA, IRENE M · 2009 to 2010
$3.0M
Epidemiology and Etiology of Hospitalized Pneumonia in ChildrenU18IP000303 · IP · UNIVERSITY OF UTAH · PI AMPOFO, KROW · 2009 to 2010
$1.6M
Rapid Molecular Testing for Neonatal Antibiotic-Resistant PathogensK23AI079401 · NIAID · UNIVERSITY OF UTAH · PI BLASCHKE, ANNE J. · 2009 to 2012
$549k
NCIRD CDC HHS 1U18IP000303NCIRD CDC HHS U18 IP000303NIAID NIH HHS 1K23AI079401NIAID NIH HHS 1U01AI074419NIAID NIH HHS 1U01AI082184NIAID NIH HHS K23 AI079401NIAID NIH HHS U01 AI074419NIAID NIH HHS U01 AI082184
6 · The paper itself

Abstract

Streptococcus pneumoniae is both an aggressive pathogen and a normal part of the human respiratory microbiome. Clinicians and microbiologists have struggled to develop tests that can identify pneumococcal respiratory infection and accurately distinguish colonization from invasive disease. Molecular methods hold the promise of an improved ability to rapidly detect microorganisms in respiratory secretions and to make an accurate diagnosis; however, interpretation of diagnostic testing for S. pneumoniae remains problematic. Molecular assays, such as those targeting the pneumolysin gene, may cross-react with other streptococcal species, confounding detection and quantification. Assays that target the autolysin gene appear to be more specific. Even when accurately identified, however, the significance of S. pneumoniae DNA detected in clinical samples is difficult to determine. Here we will discuss the challenges faced in the interpretation of molecular testing for S. pneumoniae, and some strategies that might be used to improve our ability to diagnose pneumococcal respiratory infection.

Indexed as

Bacteriological TechniquesCarrier StateHumansPneumococcal InfectionsSensitivity and SpecificityStreptococcus pneumoniae

Identifiers

PMID21460292
PMCPMC3069982
OpenAlexW2116733480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.